NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

AURO LABORATORIES

BSE: 530233 21 Feb 2025
Healthcare
₹ 232.0
Auro Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

AURO LABORATORIES - Share Price & Details

Market Cap
₹145.0
High /Low
307.0 / 137.0
Stock P/E
41.6
Book Value
₹69.6
Dividend Yield
0.0
ROCE
20.4
ROE
₹20.5
Face Value
10.0
PEG Ratio
3.44
EVEBITDA
₹29.9
Debt
34.2
CMP / FCF
-15.0
Debt to equity
₹0.79
NP Ann
7.79
High price all time
307.0
Piotroski score
₹6.0
Graham Number
93.5
No. Eq. Shares
0.62
Net CF
₹-0.77
Net profit
3.48
Price to book value
3.34
Interest Coverage
₹10.6
Low price all time
1.94
Industry PE
27.6
Reserves
₹37.1
Free Cash Flow
₹-16.8

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
AURO LABORATORIES LTD.30.550.0841.6
BILCARE LTD.1,981.30-3.05
Smruthi Organics Limited312.501.2944.6

Peer Comparison Chart


About AURO LABORATORIES

Auro Laboratories Ltd., with Security Code 530233, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Buy Auro Pharma & IPCA Labs; sell BHEL: Religare shares maiden weekly calls for 2025

(02 Jan 2025)
"The strength in the pharma and healthcare sectors, along with selective buying in heavyweight stocks, is helping Nifty to curb the pace of...
Read more →

Auro Laboratories Receives 'Hold' Rating from MarketsMOJO, Shows Strong Performance in Past Year

(04 Dec 2024)
Auro Laboratories, a microcap pharmaceutical company, has recently received a 'Hold' rating from MarketsMOJO. This upgrade is based on the company's high...
Read more →

Metformin Market Report 2024 - Share And Growth Opportunities

(25 Nov 2024)
Global metformin market size is expected to reach $5.50 Bn by 2028 at a rate of 7.2%, segmented as by product type, standard-release tablets...
Read more →

Tobramycin Eye Drop Global Market Report 2024-2033: Size & Share | Growth Forecasts

(24 Nov 2024)
Global tobramycin eye drop market size is expected to reach $1.37 Bn by 2028 at a rate of 12.4%, segmented as by product type,...
Read more →

Biguanides Market 2024 Report Presents an Inside Look at Trends, Growth

(20 Nov 2024)
Global biguanides market size is expected to reach $5.76 Bn by 2028 at a rate of 3.8%, segmented as by type, metformin, phenformin,...
Read more →

Auro Laboratories' Q2 financial report shows mixed results, with declining sales and profits.

(18 Nov 2024)
Auro Laboratories, a microcap pharmaceutical company, recently declared its financial results for the quarter ending September 2024.
Read more →